This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Maria Alonso, Ph.D.
Full Professor at CIMUS Research Institute
Speaker

Profile

María José Alonso is Professor of Pharmaceutical Technology at the University of Santiago de Compostela, Spain. Her lab has pioneered numerous discoveries in the field of nanomedicine, notably in the design of novel nanovaccines and nanotherapies for the treatment of cancer.

She has coordinated several research consortia financed by the WHO, the Gates Foundation and the European Commission and has authored more than 315 scientific contributions with H factor 100. She is the inventor of 22 patent families, most of them licensed to industry and she has been part of 3 start-up ventures. Because of the quality of her scientific articles, she has been among the TOP TEN in Pharmacology (Times Higher Education international ranking, 2010). Recently, she become part of the “Power List” of the most influential researchers in the field of Biopharmaceuticals (The Medicine Maker, 2020, 2021)

She has served to the Release Society (CRS) for 15 years and become President of the CRS in 2018. She is also Editor-in-Chief of the Drug Delivery and Translational Research, an official journal of the CRS, and she is part of the editorial board of 12 journals.

She has received more than 50 awards, among them the “National Research Award Juan de la Cierva”, “Jaume I Award”, Award of Excellence in Research and Education granted by the Ministry of Sciences and Innovation”, the “Founders Award” and the “Women in Sciences Award” of the CRS. She is a fellow of the AIMBE and a Fellow of the CRS, a member of the Royal Academy of Pharmacy of Spain, the Royal Academy of Sciences of Galicia, the Royal Academy of Pharmacy in Galicia a member of the Royal Academy of Medicine of Belgium and a member of the US National Academy of Medicine (NAM). Recently, she was awarded with an “Honoris Causa” doctorate by the University of Nottingham.

Agenda Sessions

  • Tailoring Lipid-based Nanocarriers for Site-specific RNA Delivery

    10:30